C-TAC’s Response to CDC Clinical Practice Guideline for Prescribing Opioids

CTAC + Apr 11, 2022

C-TAC provides comments on the sections of the revised CDC Clinical Practice Guideline for Prescribing Opioids regarding their effect on those living with serious illness.

View Resource

Tags:

Request for Information (RFI)

C-TAC’s Response to CDC Clinical Practice Guideline for Prescribing Opioids

C-TAC’s Response to AHRQ’s Proposed Patient-Centered Outcomes Research Trust Fund Strategic Framework

C-TAC Responds to Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies

C-TAC’s Response to the CMS Proposed Home Health Rule

C-TAC’s Response to CDC Clinical Practice Guideline for Prescribing Opioids

C-TAC’s Response to AHRQ’s Proposed Patient-Centered Outcomes Research Trust Fund Strategic Framework

C-TAC Responds to Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies

C-TAC’s Response to the CMS Proposed Home Health Rule

The Blue Chair Initiative

Search News & Resources